NASDAQ · QCLSHealthcareDiagnostics

Q/C Technologies financials

$0.8933+7.25%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
Revenue$0.00
Gross profit$0.00
Gross margin—
Operating income-$9.8M
Net income-$15.0M
Net margin—
Diluted EPS$-8.66
EBITDA-$9.8M
Operating cash flow-$9.1M
Free cash flow-$9.1M
Diluted shares1.7M

Balance sheet

Period endDec 31
Cash & equivalents$987.0K
Short-term investments$14.8M
Total debt$0.00
Total assets$41.2M
Total liabilities$16.4M
Shareholders' equity$21.8M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology